ACT on Cancer
A campaign to help transform facilities, services and research for cancer patients at Addenbrooke's.
By 2020, almost one in two Britons will get cancer in their lifetime, and it is reassuring that we have cancer services at Addenbrooke’s which are among the best in the country.
But the hospital’s cancer care facilities and equipment do not reflect the same high standards as its clinical results. The hospital is running at capacity and, with the growing population, it is predicted that staff will see over 3,300 more cancer patients a year by 2020. So ambitious plans are needed to provide the best patient experience and radically transform cancer services in line with 21st century requirements.
Our ACT on Cancer campaign aims to raise funds in support of the following areas.
1. Transforming facilities for cancer patients
Patients at Addenbrooke’s already receive excellent treatment, with outcomes consistently above the national average. However, facilities are outdated and increasingly crowded.
2. Supporting innovative technologies and personalised treatments
Addenbrooke’s strives to offer cancer patients cutting-edge diagnosis and treatment. Charitable support for the latest technologies and therapies is needed now to ensure such excellence continues.
3. Fostering the future leaders of clinical cancer research
Addenbrooke’s is recognised as a centre of excellence where ideas created in the laboratory are translated into benefits for patients. ACT supports this by providing highly valued funding for early stage research.
You can make a difference
We need to ACT on Cancer now to ensure that patients receive a better service and can benefit to a greater extent from the world-class scientific advances being developed right here on our doorstep. The need for change is urgent and the case compelling. By supporting the ACT on Cancer campaign, you will make a real difference for local cancer patients.
Watch our video below to hear from Sally Newman and Simon Hardwick about their experiences of being treated for cancer at Addenbrooke's.